Arbe Robotics selected Synopsys’ IP for its high performance and ASIL D Ready safety features that are well-suited for strict ADAS and autonomous vehicle application requirements.
Read more on PR Newswire here.
![[Alpha Tau in Yahoo Finance] Alpha Tau Receives FDA’s Breakthrough Device Designation for the Treatment of Recurrent GBM](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
[Alpha Tau in Yahoo Finance] Alpha Tau Receives FDA’s Breakthrough Device Designation for the Treatment of Recurrent GBM
October 8, 2021
[Alpha Tau in Globes] Alpha Tau Announces the Publication of Exceptional Clinical Data from Alpha DaRT, its Novel Alpha Radiotherapy for Solid Tumors
December 2, 2019
